Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology
Given the existence of various risks associated with TNFi usage, this clinical perspective overview of Portuguese experts in PsO treatment emphasizes the need for a tailored therapeutic framework in the management of PsO.
Authors
- Sofia Magina (ORCID: https://orcid.org/0000-0002-9185-0216)
- Maria João Paiva Lopes (ORCID: https://orcid.org/0000-0001-9189-2734)
- Tiago Torres (ORCID: https://orcid.org/0000-0003-0404-0870)
Institutions
- Universidade do Porto (PT)
- Hospital de São João (PT)
- Unidade Local de Saúde de São José (PT)
- Hospital de São José (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Centro Universitário de João Pessoa (BR)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1080/09546634.2025.2453601
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johnson and Johnson